[go: up one dir, main page]

ECSP13013069A - Composiciones estables de povidona-yodo con esteroides o antiinflamatorios no esteroideos - Google Patents

Composiciones estables de povidona-yodo con esteroides o antiinflamatorios no esteroideos

Info

Publication number
ECSP13013069A
ECSP13013069A ECSP13013069A ECSP13013069A EC SP13013069 A ECSP13013069 A EC SP13013069A EC SP13013069 A ECSP13013069 A EC SP13013069A EC SP13013069 A ECSP13013069 A EC SP13013069A
Authority
EC
Ecuador
Prior art keywords
iodine
povidona
inflammatories
stable compositions
steroid
Prior art date
Application number
Other languages
English (en)
Inventor
Joseph A Capriotti
C Michael Samson
Jason Stein
Michael Weiser
Original Assignee
Foresight Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47139697&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP13013069(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Foresight Biotherapeutics Inc filed Critical Foresight Biotherapeutics Inc
Publication of ECSP13013069A publication Critical patent/ECSP13013069A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Anesthesiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se revelan composiciones estables las cuales comprenden povidona-yodo y un esteroide y métodos de fabricación y uso de dichas composiciones. Se revelan también en el presente documento composiciones estables que comprenden povidona-yodo y compuestos antiinflamatorios no esteroideos (NSAID, por sus siglas en inglés) y métodos de fabricación y uso de dichas composiciones.
ECSP13013069 2011-05-12 2013-12-09 Composiciones estables de povidona-yodo con esteroides o antiinflamatorios no esteroideos ECSP13013069A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161485475P 2011-05-12 2011-05-12
PCT/US2012/037563 WO2012155062A1 (en) 2011-05-12 2012-05-11 Stable povidone-iodine compositions with steroids or non-steroidal anti-inflammatories

Publications (1)

Publication Number Publication Date
ECSP13013069A true ECSP13013069A (es) 2015-03-31

Family

ID=47139697

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP13013069 ECSP13013069A (es) 2011-05-12 2013-12-09 Composiciones estables de povidona-yodo con esteroides o antiinflamatorios no esteroideos

Country Status (16)

Country Link
US (1) US20150038473A1 (es)
EP (1) EP2707006B1 (es)
JP (2) JP6072009B2 (es)
KR (1) KR101967938B1 (es)
CN (1) CN103957922A (es)
AR (1) AR086399A1 (es)
AU (3) AU2012253335B2 (es)
BR (1) BR112013028735A2 (es)
CA (1) CA2835343A1 (es)
CL (1) CL2013003016A1 (es)
CO (1) CO6821949A2 (es)
EC (1) ECSP13013069A (es)
MX (1) MX360666B (es)
PE (1) PE20141070A1 (es)
TW (2) TWI632914B (es)
WO (1) WO2012155062A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2665195B2 (ja) 1995-05-19 1997-10-22 日本電気移動通信株式会社 Ｍｃａシステムにおける移動局の個別番号表示方法
US7767217B2 (en) 2006-03-14 2010-08-03 Foresight Biotherapeutics Ophthalmic compositions comprising povidone-iodine
TW202023575A (zh) * 2011-09-16 2020-07-01 美商遠景生物製藥股份有限公司 安定之普維酮—碘組成物
AU2013256064B2 (en) 2012-05-03 2018-01-04 Alcon Inc. Pharmaceutical nanoparticles showing improved mucosal transport
KR102140989B1 (ko) 2012-05-03 2020-08-04 칼라 파마슈티컬스, 인크. 개선된 점막 수송을 나타내는 제약 나노입자
US9827191B2 (en) 2012-05-03 2017-11-28 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
US11596599B2 (en) 2012-05-03 2023-03-07 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
CA2900652C (en) 2013-02-15 2021-05-04 Kala Pharmaceuticals, Inc. Therapeutic compounds and uses thereof
EP2956143A4 (en) * 2013-02-15 2016-09-28 Senju Pharma Co DIFLUPREDNATE EMULSION COMPOSITION WITH AN ANTIMICROBIAL METAL
KR102277833B1 (ko) 2013-02-20 2021-07-14 칼라 파마슈티컬스, 인크. 치료 화합물 및 그의 용도
US9688688B2 (en) 2013-02-20 2017-06-27 Kala Pharmaceuticals, Inc. Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
CN106061261B (zh) 2013-11-01 2018-04-24 卡拉制药公司 治疗化合物的结晶形式及其用途
US9890173B2 (en) 2013-11-01 2018-02-13 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
WO2016172712A2 (en) 2015-04-23 2016-10-27 Sydnexis, Inc. Ophthalmic composition
US9463201B2 (en) * 2014-10-19 2016-10-11 M.G. Therapeutics Ltd Compositions and methods for the treatment of meibomian gland dysfunction
HK1248570A1 (zh) 2015-05-29 2018-10-19 西德奈克西斯公司 D2o稳定化的药物制剂
PL3416654T3 (pl) 2016-02-18 2022-03-21 Invirsa, Inc. Medyczne zastosowanie adenozyno-5'-difosforanu rybozy (adpr)
JP6919970B2 (ja) 2016-04-14 2021-08-18 アズーラ オフサルミックス エルティーディー． マイボーム腺機能不全の処置において使用される二硫化セレン組成物
KR20190005179A (ko) * 2016-05-05 2019-01-15 벨로체 바이오파르마 엘엘씨 눈의 염증 또는 감염의 치료를 위한 조성물 및 방법
JP2019533641A (ja) 2016-09-08 2019-11-21 カラ ファーマシューティカルズ インコーポレイテッド 治療用化合物の結晶形態およびその使用
EP3509422A4 (en) 2016-09-08 2020-05-20 Kala Pharmaceuticals, Inc. CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF
WO2018048750A1 (en) 2016-09-08 2018-03-15 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
KR101935250B1 (ko) * 2017-07-04 2019-01-04 김대황 요오드제 및 삼투성 미각제를 포함하는 눈, 구강용, 비강용 또는 흡입용 항바이러스 및 항균 조성물
EP4226971A1 (en) 2018-03-27 2023-08-16 Invirsa, Inc. Methods for the use of 5'-adenosine diphosphate ribose (adpr)
WO2021140417A2 (en) 2020-01-10 2021-07-15 Azura Ophthalmics Ltd. Instructions for composition and sensitivity
CN116370408B (zh) * 2020-06-17 2025-12-02 成都瑞沐生物医药科技有限公司 一种滴眼给药治疗黄斑水肿、视神经炎和非感染性眼内炎的眼用制剂
CN112305115B (zh) * 2020-10-29 2022-08-23 诺峰药业(成都)有限公司 一种检测二氟泼尼酯眼用乳剂中的降解杂质及其含量的高效液相色谱方法
KR20220062790A (ko) 2020-11-09 2022-05-17 정춘영 포비돈 아이오딘계 소독액
KR102489633B1 (ko) * 2021-01-21 2023-01-17 주식회사태준제약 점안 조성물
US20240299291A1 (en) * 2021-01-22 2024-09-12 Chengdu Ruimu Biopharmaceuticals Co., Ltd. Ophthalmic preparation administered by eye drops and used for preventing and treating dry macular degeneration and retinal light damage

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886268A (en) 1972-05-30 1975-05-27 Synergistics Iodophor-steroid compound pharmaceutical compositions
US7767217B2 (en) * 2006-03-14 2010-08-03 Foresight Biotherapeutics Ophthalmic compositions comprising povidone-iodine
NZ603346A (en) * 2008-06-12 2014-05-30 Foresight Biotherapeutics Inc Povidone iodine, a novel alternative preservative for ophthalmic compositions
WO2011084473A1 (en) * 2009-12-15 2011-07-14 Foresight Biotherapeutics, Inc. Non-irritating ophthalmic povidone-iodine compositions
TW202023575A (zh) * 2011-09-16 2020-07-01 美商遠景生物製藥股份有限公司 安定之普維酮—碘組成物

Also Published As

Publication number Publication date
AU2016222491A1 (en) 2016-09-22
AU2012253335B2 (en) 2016-08-04
CA2835343A1 (en) 2012-11-15
EP2707006B1 (en) 2019-07-03
TW201811340A (zh) 2018-04-01
MX2013012971A (es) 2013-12-12
TW201311256A (zh) 2013-03-16
JP6072009B2 (ja) 2017-02-01
JP6359619B2 (ja) 2018-07-18
MX360666B (es) 2018-11-13
WO2012155062A1 (en) 2012-11-15
AR086399A1 (es) 2013-12-11
JP2014516954A (ja) 2014-07-17
CL2013003016A1 (es) 2014-05-02
BR112013028735A2 (pt) 2017-12-05
PE20141070A1 (es) 2014-09-14
EP2707006A1 (en) 2014-03-19
CN103957922A (zh) 2014-07-30
TWI632914B (zh) 2018-08-21
TWI717552B (zh) 2021-02-01
KR20140045375A (ko) 2014-04-16
EP2707006A4 (en) 2014-09-24
KR101967938B1 (ko) 2019-04-10
JP2017095474A (ja) 2017-06-01
CO6821949A2 (es) 2013-12-31
AU2012253335A1 (en) 2013-05-02
AU2018203492A1 (en) 2018-06-07
US20150038473A1 (en) 2015-02-05

Similar Documents

Publication Publication Date Title
ECSP13013069A (es) Composiciones estables de povidona-yodo con esteroides o antiinflamatorios no esteroideos
CL2017001952A1 (es) Composiciones estables de povidona-yodo con esteroides o antiinflamatorios no esteroideos (divisional solicitud 592-2014)
MX2018005265A (es) Composiciones pesticidas y procesos relacionados a las mismas.
CR20140450A (es) Composicion para el control de plagas que incluye un derivado de iminopiridina novedoso
BRPI1014956A2 (pt) agentes antinflamatórios.
CO6311002A2 (es) Agentes fijadores y epitopos wise
FR3002534B1 (fr) Substrat revetu d'un empilement bas-emissif.
UY34234A (es) Inhibidores de la replicación de los virus de la gripe
AR069474A1 (es) Material anticorrosivo
UY34119A (es) Montaje machihembrado de fijación
DK3186372T3 (da) Solubilisering af kommunalt fast affald (MSW) ved hjælp af en enzymblanding
EP3305447A4 (en) HIGHLY EFFICIENT STEP-STRUCTURED SPIRAL DRILL
EP2795790A4 (en) VOLTAGE-CONTROLLED OSCILLATOR WITH REDUCED UNSYMMETRIC CAPACITY
BRPI1014361A2 (pt) fonte de evaporação por arco e método para formação de películas que utiliza a mesma
EP2973724A4 (en) Iii-nitride transistor with engineered substrate
DK3523315T3 (da) Inhibitor af glucocorticoidreceptor
CL2016002338A1 (es) Uso de un compuesto que es ácido r-2-4-2-etoxi-3-4-trifluorometilfenoxipropil-tio-2-metilfenoxi acético, para el tratamiento de una enfermedad colestásica intrahepática .
CL2008002551A1 (es) Aducto amina-funcional; composicion curable, multicomponentes ; sustrato recubierto con dicha composicion; y procedimiento para proveer un recubrimiento a un sustrato
CL2008002705A1 (es) Composicion herbicida que comprende un compuesto con estructura piridazinona; metodo de control de malezas; uso del compuesto con estructura piridazinona para el control de malezas.
HN2009003469A (es) Biscocho lleno
MX2023008764A (es) Composiciones y metodos para prevenir y tratar afecciones.
BR112013032553A2 (pt) composto, composição, substrato, e, processos de marcação e de obtenção de um composto
ATE512673T1 (de) Farbige esmolol-konzentrate
CL2015000610A1 (es) Derivados de isoxazolidina
MX2015014307A (es) Administracion de farmacos antiinflamatorios no esteroidales y composiciones, metodos y sistemas relacionados.